Oscar Health, Inc. (NYSE:OSCR) Director Elbert O. Jr. Robinson Sells 25,000 Shares

Oscar Health, Inc. (NYSE:OSCR) Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $17.05, for a total value of $426,250.00. Following the completion of the sale, the director now owns 89,512 shares of the company’s stock, valued at $1,526,179.60. The trade was a 21.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Oscar Health Trading Down 2.0 %

Oscar Health stock opened at $15.98 on Monday. Oscar Health, Inc. has a 52 week low of $7.29 and a 52 week high of $23.79. The stock has a 50-day moving average price of $17.90 and a 200 day moving average price of $18.18. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $3.95 billion, a price-to-earnings ratio of -266.33 and a beta of 1.67.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business had revenue of $2.42 billion during the quarter, compared to analysts’ expectations of $2.33 billion. During the same period last year, the company earned ($0.29) earnings per share. The firm’s revenue was up 68.3% on a year-over-year basis. Sell-side analysts anticipate that Oscar Health, Inc. will post -0.01 EPS for the current year.

Hedge Funds Weigh In On Oscar Health

A number of institutional investors have recently modified their holdings of the stock. Versor Investments LP acquired a new stake in Oscar Health during the third quarter worth about $787,000. Janney Montgomery Scott LLC purchased a new stake in Oscar Health in the 3rd quarter worth approximately $988,000. Assenagon Asset Management S.A. grew its stake in shares of Oscar Health by 32.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock worth $32,368,000 after purchasing an additional 507,009 shares during the period. FCG Investment Co purchased a new position in shares of Oscar Health during the 3rd quarter valued at approximately $986,000. Finally, Toth Financial Advisory Corp lifted its stake in shares of Oscar Health by 73,185.7% in the 3rd quarter. Toth Financial Advisory Corp now owns 51,300 shares of the company’s stock valued at $1,088,000 after purchasing an additional 51,230 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on OSCR. Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and lowered their target price for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. UBS Group began coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target for the company. Finally, Piper Sandler restated an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research note on Tuesday, September 10th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $22.93.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.